<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">epilepsia</journal-id><journal-title-group><journal-title xml:lang="en">Epilepsy and paroxysmal conditions</journal-title><trans-title-group xml:lang="ru"><trans-title>Эпилепсия и пароксизмальные состояния</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2077-8333</issn><issn pub-type="epub">2311-4088</issn><publisher><publisher-name>IRBIS LLC</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">epilepsia-164</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group></article-categories><title-group><article-title>ELECTROPHYSIOLOGICAL MECHANISMS OF ANTIEPILEPTIC ACTIONS REALIZATION OF BEPRODON</article-title><trans-title-group xml:lang="ru"><trans-title>ЭЛЕКТРОФИЗИОЛОГИЧЕСКИЕ МЕХАНИЗМЫ РЕАЛИЗАЦИИ ПРОТИВОЭПИЛЕПТИЧЕСКОГО ДЕЙСТВИЯ БЕПРОДОНА</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Воронина</surname><given-names>Т. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Voronina</surname><given-names>T. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Воронина Татьяна Александровна – профессор, доктор медицинских наук, руководитель лаборатории психофармакологии. </p><p>Адрес: Балтийская ул. 8, г. Москва, 125315.</p></bio><bio xml:lang="en"><p>Voronina Tat'yana Aleksandrovna – professor, MD, head of the Laboratory. </p><p>Address: Baltiiskaya str., 8, Moscow, 125315.</p></bio><email xlink:type="simple">voroninata38@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Неробкова</surname><given-names>Л. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Nerobkova</surname><given-names>L. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Неробкова Любовь Николаевна – кандидат биологических наук, старший научный сотрудник лаборатории психофармакологии. </p><p>Адрес: Балтийская ул. 8, г. Москва, 125315.</p></bio><bio xml:lang="en"><p>Nerobkova Lyubov' Nikolaevna – Ph.D., Senior Research Fellow. </p><p>Address: Baltiiskaya str., 8, Moscow, 125315.</p></bio><email xlink:type="simple">Ln_Nerobkova@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Авакян</surname><given-names>Г. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Avakyan</surname><given-names>G. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Авакян Гагик Норайрович – доктор медицинских наук, заслуженный деятель науки РФ, профессор кафедры неврологии и нейрохирургии. </p><p>Адрес: ул. Островитянова, д. 1, г. Москва, 117997.</p></bio><bio xml:lang="en"><p>Avakyan Gagik Norairovich – MD, Honored Scientist of Russia, Professor of Neurology and Neurosurgery. </p><p>Address: Ostrovityanova str., 1.Moscow. 117997.</p><p> </p></bio><email xlink:type="simple">gavakyan@yandex.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бахуташвили</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Bakhutashvili</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Бахуташвили Александр Владимирович – доктор медицинских наук, генеральный директор.</p><p>Адрес: ул. Саляма Адиля, д 9, корп 3, г. Москва, 123154.</p></bio><bio xml:lang="en"><p>Bakhutashvili Aleksandr Vladimirovich – Ph.D., General Director. </p><p>Address: Salyama Adilya str., 9, Moscow, 123154.</p></bio><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Авакян</surname><given-names>Г. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Avakyan</surname><given-names>G. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Авакян Георгий Гагикович – кандидат медицинских наук, ассистент кафедры неврологии, нейрохирургии и медицинской генетики. </p><p>Адрес: ул. Островитянова, д. 1, г. Москва, 117997.</p></bio><bio xml:lang="en"><p>Avakyan Georgii Gagikovich – MD, PhD, Department of Neurology, Neurosurgery and Medical Genetics.</p><p>Address: Ostrovityanova str., 1.Moscow. 117997</p></bio><email xlink:type="simple">gavakyan@yandex.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Капица</surname><given-names>И. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Kapitsa</surname><given-names>I. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Капица Инга Геннадиевна – кандидат биологических наук, старший научный сотрудник лаборатории психофармакологии. </p><p>Адрес: Балтийская ул. 8, г. Москва, 125315.</p></bio><bio xml:lang="en"><p>Kapitsa Inga Gennad’evna – PhD, Senior Researcher. </p><p>Address: Baltiiskaya str., 8, Moscow, 125315.</p></bio><email xlink:type="simple">Ingakap73@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гайдуков</surname><given-names>И. О.</given-names></name><name name-style="western" xml:lang="en"><surname>Gaidukov</surname><given-names>I. O.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Гайдуков Игорь Олегович – аспирант. </p><p>Адрес: Балтийская ул. 8, г. Москва, 125315</p></bio><bio xml:lang="en"><p>Gaidukov Igor’ Olegovich – Post-graduate. </p><p>Address: Baltiiskaya str., 8, Moscow, 125315.</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ковалев</surname><given-names>И. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Kovalev</surname><given-names>I. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ковалев Иван Георгиевич – аспирант. </p><p>Адрес: Балтийская ул. 8, г. Москва, 125315.</p></bio><bio xml:lang="en"><p>Kovalev Ivan Georgievich – Post-graduate. </p><p>Address: Baltiiskaya str., 8, Moscow, 125315.</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Научно-исследовательский институт фармакологии имени В. В. Закусова РАМН, Москва</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Institute of Pharmacology named V. V. Zakusov, Moscow</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Российский национальный исследовательский медицинский университет имени Н. И. Пирогова</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Pirogov Russian National Research Medical University, Moscow</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>Ксенова, ООО, Москва</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Xenova LLC, Moscow</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2015</year></pub-date><pub-date pub-type="epub"><day>11</day><month>06</month><year>2016</year></pub-date><volume>7</volume><issue>1</issue><fpage>8</fpage><lpage>19</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Voronina T.A., Nerobkova L.N., Avakyan G.N., Bakhutashvili A.V., Avakyan G.G., Kapitsa I.G., Gaidukov I.O., Kovalev I.G., 2016</copyright-statement><copyright-year>2016</copyright-year><copyright-holder xml:lang="ru">Воронина Т.А., Неробкова Л.Н., Авакян Г.Н., Бахуташвили А.В., Авакян Г.Г., Капица И.Г., Гайдуков И.О., Ковалев И.Г.</copyright-holder><copyright-holder xml:lang="en">Voronina T.A., Nerobkova L.N., Avakyan G.N., Bakhutashvili A.V., Avakyan G.G., Kapitsa I.G., Gaidukov I.O., Kovalev I.G.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.epilepsia.su/jour/article/view/164">https://www.epilepsia.su/jour/article/view/164</self-uri><abstract><p>The purpose of this research was to study electric and physiological mechanisms of the achievement of the antoconvulsant effect of the new original beprodon combination together with determination of determinant brain structures – therapeutic targets.</p><sec><title>Materials and Methods</title><p>Materials and Methods. Partial (focal) and secondary generalized convulsions were generated using the method of creation of a chronic epileptogenic focus, caused by the cobalt application on rats’ brain.</p></sec><sec><title>Results</title><p>Results: it was revealed, that at the first stage of the epileptic system (ES) beprodone is targeted to cortical focuses, and at the second stage – to subcortical focuses, generating epileptic activities. Conclusion: the beprodone effect depends on the stage of the epileptic system development and is targeted to determinant focuses.</p></sec></abstract><trans-abstract xml:lang="ru"><p>Целью настоящего исследования было изучение электрофизиологических механизмов реализации противосудорожного эффекта нового оригинального соединения бепродона с определением детерминантных структур мозга – мишеней воздействия.</p><sec><title>Методика исследования</title><p>Методика исследования. Моделирование парциальных (фокальных) и вторичногенерализованных судорог проведено с использованием методики создания хронического эпилептогенного очага, вызванного аппликацией кобальта на мозг крыс.</p></sec><sec><title>Результаты исследования</title><p>Результаты исследования: выявлено, что на первой стадии развития эпилептической системы (ЭС) мишенями действия бепродона являются корковые, а на второй стадии – подкорковые очаги, которые являются генераторами эпилептической активности. Заключение: эффект бепродона зависит от стадии развития эпилептической системы и направлен на детерминатные очаги.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>Бепродон</kwd><kwd>противосудорожный эффект</kwd><kwd>эпилептическая система</kwd><kwd>корковые и подкорковые детерминатные очаги</kwd></kwd-group><kwd-group xml:lang="en"><kwd>Beprodon</kwd><kwd>anticonvulsant effect</kwd><kwd>epileptic system</kwd><kwd>cortical and subcortical determinate centers</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Авакян Г.Н., Неробкова Л.Н., Воронина Т.А., Маркина Н.В. Митрофанов А.А. Влияние карбамазепина на структурнофункциональные связи в развитии эпилептической системы. Экспериментальная и клиническая фармакология. 2002; 2: 7-10.</mixed-citation><mixed-citation xml:lang="en">Avakyan G.N., Nerobkova L.N., Voronina T.A., Markina N.V. Mitrofanov A.A. Eksperimental’naya i klinicheskaya farmakologiya. 2002; 2: 7-10.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Воронина Т.А., Неробкова Л.Н., Стойко М.И., Авакян Г.Н. Анализ влияния фенитоина на распространение судорог и эпилептический статус, вызванный нейротоксином гомоцистеином тиалактоном у крыс с кобальтовой эпилепсией. Экспериментальная и клиническая фармакология. 2003; 66 (1): 5-8.</mixed-citation><mixed-citation xml:lang="en">Voronina T.A., Nerobkova L.N., Stoyko M.I., Avakyan G.N. Eksperimental’naya i klinicheskaya farmakologiya. 2003; 66 (1): 5-8.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Воронина Т.А., Неробкова Л.Н. Руководство по проведению доклинических исследований лекарственных средств: методические указания по изучению противосудорожной активности фармакологических веществ. Часть 1. Глава 14. М. 2012; 235-250.</mixed-citation><mixed-citation xml:lang="en">Voronina T.A., Nerobkova L.N. Guidelines for preclinical studies of drugs: guidelines for the study of anticonvulsant activity of pharmacological substances. Part 1. Chapter 14 [Rukovodstvo po provedeniyu doklinicheskikh issledovaniy lekarstvennykh sredstv: metodicheskie ukazaniya po izucheniyu protivosudorozhnoy aktivnosti farmakologicheskikh veshchestv. Chast’ 1. Glava 14]. Moscow. 2012; 235-250.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Butler A.B., Willmore L.J., Fuller P.M., Bass N.H. Focal alteration of dendrites and astrocytes in rat cerebral cortex during initiation of cobalt-induced epileptiform activity. Exp Neurol. 1976 Apr; 51 (1): 216-28.</mixed-citation><mixed-citation xml:lang="en">Butler A.B., Willmore L.J., Fuller P.M., Bass N.H. Focal alteration of dendrites and astrocytes in rat cerebral cortex during initiation of cobalt-induced epileptiform activity. Exp Neurol. 1976 Apr; 51 (1): 216-28.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Bregman F., Le Saux S., Trottier L., Chauvel P., Maurin Y. Chronic Cobalt-induced Epilepsy: Noradrenaline Ionophoresis and Adrenoceptor Binding Studies in the Rat Cerebral Cortex. J. Neural Transmission. 1985; 63: 109-118.</mixed-citation><mixed-citation xml:lang="en">Bregman F., Le Saux S., Trottier L., Chauvel P., Maurin Y. Chronic Cobalt-induced Epilepsy: Noradrenaline Ionophoresis and Adrenoceptor Binding Studies in the Rat Cerebral Cortex. J. Neural Transmission. 1985; 63: 109-118.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Chang L.W., Payan H.M. Cobaltinduced epilepsy: an ultrastructural study. Neurol Res. 1979; 1 (1): 19-29.</mixed-citation><mixed-citation xml:lang="en">Chang L.W., Payan H.M. Cobaltinduced epilepsy: an ultrastructural study. Neurol Res. 1979; 1 (1): 19-29.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Clayton P.R., Emson P.C. Spread of cobalt from a cortical epileptic lesion induced by a cobalt-gelatine implant into the frontal cortes of the rat. Experientia. 1976 Oct 15; 32 (10): 1303-5.</mixed-citation><mixed-citation xml:lang="en">Clayton P.R., Emson P.C. Spread of cobalt from a cortical epileptic lesion induced by a cobalt-gelatine implant into the frontal cortes of the rat. Experientia. 1976 Oct 15; 32 (10): 1303-5.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">He J., Hsiang H.L., Wu C, Mylvagnanam S., Carlen P.L., Zhang L. Cellular mechanisms of cobalt-induced hippocampal epileptiform discharges. Epilepsia. 2009 Jan; 50 (1): 99-115.</mixed-citation><mixed-citation xml:lang="en">He J., Hsiang H.L., Wu C, Mylvagnanam S., Carlen P.L., Zhang L. Cellular mechanisms of cobalt-induced hippocampal epileptiform discharges. Epilepsia. 2009 Jan; 50 (1): 99-115.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Hyon Mee Chun, Jae Moon Kim1, Young Ho Lee. Pattern of Hippocampal Cell Changes in Cobalt / Homocysteine induced Status Epilepticus. The Korean J. Anat. 2002; 35 (1): 37-42.</mixed-citation><mixed-citation xml:lang="en">Hyon Mee Chun, Jae Moon Kim1, Young Ho Lee. Pattern of Hippocampal Cell Changes in Cobalt / Homocysteine induced Status Epilepticus. The Korean J. Anat. 2002; 35 (1): 37-42.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Sugaya E., Ishige A., Sediguchi K., Yuzurihara M., Iizuka S., Sugimoto A., Hosoya E. Damage of hippocampal neurons caused by cobalt focus in the cerebral cortex of rats. Brain Res. 1988 Aug 30; 459 (1): 196-9.</mixed-citation><mixed-citation xml:lang="en">Sugaya E., Ishige A., Sediguchi K., Yuzurihara M., Iizuka S., Sugimoto A., Hosoya E. Damage of hippocampal neurons caused by cobalt focus in the cerebral cortex of rats. Brain Res. 1988 Aug 30; 459 (1): 196-9.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Trottier S., Berger B., Chauvel P., Dedek J., Gay M. Alterations of the cortical noradrenergic system in chronic cobalt epileptogenic foci in the rat: A histofluorescent and biochemical study Neuroscience. 1981; 6: 1069-1080.</mixed-citation><mixed-citation xml:lang="en">Trottier S., Berger B., Chauvel P., Dedek J., Gay M. Alterations of the cortical noradrenergic system in chronic cobalt epileptogenic foci in the rat: A histofluorescent and biochemical study Neuroscience. 1981; 6: 1069-1080.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Trottier S., Claustre Y., Caboche J., Dedek J., Chauvel P., Nassif S., Scatton B. Alterations of noradrenaline and serotonin uptake and metabolism in chronic cobaltinduced epilepsy in the rat. Brain Res. 1983 Aug 8; 272 (2): 255-62.</mixed-citation><mixed-citation xml:lang="en">Trottier S., Claustre Y., Caboche J., Dedek J., Chauvel P., Nassif S., Scatton B. Alterations of noradrenaline and serotonin uptake and metabolism in chronic cobaltinduced epilepsy in the rat. Brain Res. 1983 Aug 8; 272 (2): 255-62.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Van Ostrand G., Cooper R.M. [14C]2deoxyglucose autoradiographic technique provides a metabolic signature of cobaltinduced focal epileptogenesis. Epilepsia. 1994 Sep-Oct; 35 (5): 939-49.</mixed-citation><mixed-citation xml:lang="en">Van Ostrand G., Cooper R.M. [14C]2deoxyglucose autoradiographic technique provides a metabolic signature of cobaltinduced focal epileptogenesis. Epilepsia. 1994 Sep-Oct; 35 (5): 939-49.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Walton N.Y. et al. Lamotrigine vs. phenytoin for treatment of status epilepticus: comparison in an experimental model. Epilepsy Res. 1996; 24: 19-28.</mixed-citation><mixed-citation xml:lang="en">Walton N.Y. et al. Lamotrigine vs. phenytoin for treatment of status epilepticus: comparison in an experimental model. Epilepsy Res. 1996; 24: 19-28.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
